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1. Introduction 
Celiac disease is an autoimmune gluten-sensitive enteropathy or nontropical sprue 
occurring in genetically susceptible individuals, triggered by dietary gluten and related 
prolamins, which damage small intestine and interfere with absorption of nutrients. Tight 
junctions play an important role in the pathomechanism of different gastrointestinal 
diseases. Claudins, the main tight junction proteins are found in the monolayer of the 
gastrointestinal epithelium (Bornholdt et al., 2011). The presence and distribution of claudin 
depend on the organs and the function of the tissues (Gonzales-Mariscal et al., 2003). The 
expression levels of various claudins correlate to the distinct physiological and pathological 
conditions. Claudins modulate the permeability of the epithelial barrier (Bornholdt et al., 
2011). Surprisingly, there is only one study analyzing different claudins at protein level of 
intestinal biopsies in patients with celiac disease. At first, general information of tight 
junctions and the characteristics of claudins in different gastrointestinal disorders will be 
highlighted for a better understanding of the role of claudins in celiac disease. 
2. Characteristics of tight junctions 
Intercellular junctions are presented in multicellular organism as linking cells and 
maintaining barrier function between the two sides of cell layer (Staehelin et al., 1974). It 
plays a structural role in maintaining biological compartments, cell polarity, and a barrier 
function separating the internal and external environments (Krause et al., 2008). It also 
controls the paracellular transport (Balda et al., 1996). The barrier and fence function are 
dynamically changing and guide cell behavior. Three major types of intercellular junctions 
are the zonula occludens (tight junction), the zonula adherens (adherens junction) and the 
macula adherens (desmosome). The tight junction is an intercellular junction by interlinked 
rows of integral membrane proteins limiting the intercellular transport. One of the most 
important components of tight junction is claudin (Figure 1).  
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Fig. 1. Schematic structure of tight junctions.  
The adherent junction links cell membranes and cytoskeletal elements connecting cells 
mechanically. The gap junction containing channels regulates trespassing of ions and 
microelements through the cell layer. Tight junction, as the most apical component of 
intercellular junctional complexes in basolateral spaces, constitutes the barrier between cells 
and has a fundamental function to separate different compartments within the organism 
(Farquhar et al., 1963). Tight junctions were first described in epithelia and endothelia 
(Stevenson et al., 1988). However, recent studies suggest that they are also found in 
myelinated cells. There are more than 40 different tight junction proteins in epithelia or 
endothelia (Gonzalez-Mariscal et al., 2003). Tight junctions have a complex structure – 
cortical or transmembrane protein -, and form a continuous, circumferential belt separating 
apical and basolateral plasma membrane domains. Tight junctions play a role not only in the 
maintenance of paracellular transport, but also in the cell growth and differentiation via 
signaling cascades. Altered tight junction structures and ratios present distinct permeability 
in different tissues and have a dynamic capacity responding to the altered environmental 
conditions. Furthermore, extracellular stimuli, such as cytokines and growth factors, also 
affect the distribution of tight junctions (Steed et al., 2010). Interferon-gamma, tumor 
necrosis factor-alpha, insulinlike growth factor-I and insulinlike growth factor -II, vascular 
endothelial growth factor, interleukin-1, interleukin -4, interleukin -13, and hepatocyte 
growth factor decrease the barrier function. Adverse effect (increased or protected barrier 
function) is known by transforming growth factor-beta, epidermal growth factor, 
interleukin-10 and interleukin-17 (Dignass et al., 1993).  
Tight junctions are integral components of cells and the disturbance of the barrier function 
can lead to diseases (Sawada et al., 2003). The loss of fence function (decreased cell polarity) 
is known in cancer cells and oncogenic papillomavirus infection (Tobioka et al., 2002; 
Glaunsinger et al., 2000). The defect of barrier function and consequential deficiency of 
paracellular transport can affect the vascular system (edema, endotoxinemia, cytokinemia, 
blood-borne metastasis), liver (jaundice, primary biliary cirrhosis, primary sclerosing 
cholangitis), respiratory tract (asthma), and hereditary diseases (hypomagnesaemia, 
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deafness, cystic fibrosis) (Sawada et al., 2003; Forster et al., 2008; Furuse et al., 2009). The 
gastrointestinal tract can be affected and the deterioration of tight junctions is responsible, at 
least in part, for the increased permeability in patients with bacterial gastritis, 
pseudomembranous or collagenous colitis, Crohn’s disease, ulcerative colitis, and celiac 
disease (Schulzke et al., 2000, 2009).  
Integral proteins, such as occludins, claudins and junctional adhesion molecules, constitute 
the tight junctions, and responsible together for the maintenance of barrier function. 
Occludin was identified as the first integral membrane protein (Furuse et al., 1993). It 
appears to interact with claudins and form long tight junction strands. Its overexpression 
increases transepithelial resistance and affects the polarization and diffusion through the 
membrane. Claudins are the most important components of the backbone tight junction 
strain (Furue et al., 1998). In this chapter, claudins and their role in different gastrointestinal 
diseases will be highlighted.  
3. Characteristics of claudins 
As an integral component of tight junctions, claudins play a central role in the regulation of 
cell-cell adhesion, cell polarity and transportation of paracellular ion, water, and molecules 
(Gonzalez-Mariscal et al., 2003). Twenty-four subgroups are known (Table 1).  In general, 
claudin genes contain only some introns and several lack introns altogether. All claudin 
genes are typically small and their sequences are similar to each other. Some claudins are 
located close to each other in the human genome (Lal-Nag et al., 2009). For instance, 
claudin22 and -24 is located on chromosome 4, claudin3 and -4 on chromosome 7, claudin6 
and -9 on chromosome 16, and claudin8 and -17 on chromosome 21 (Gupta IR et al., 2010). 
Their close proximity results simultaneous regulation and expression following different 
responses. The others are located on different chromosomes giving them a slightly different 
regulation and properties. All claudins encode 20-27 kDa proteins with four transmembrane 
domains and two extracellular loops where the first one is significantly longer (around 60 
residues) than the second one (24 residues) (Krause et al., 2008). The first loop contains 
charged amino acids influencing paracellular charge selectivity. The highly conserved 
cysteine residues are present increased protein stability as formation of intermolecular 
disulfide bond. The second loop is responsible for confirmation through hydrophobic 
interactions. The short intracellular cytoplasmatic amino-terminal sequence (4 to 5 residues) 
is more conserved than the short intracellular carboxyl tail (Figure 2). The latter comprises a 
PZD-domain-binding motif (Guillemot et al, 2008). This part of claudins interacts directly 
with the tight junction-associated proteins, and determines the stability and function of 
proteins. Although claudins are known as the main component of the apical tight junctions, 
claudin can be localized in the cytoplasm as well (Acharya et al., 2004). The role of 
cytoplasm claudin is concluded in cell-matrix interactions and vesicle trafficking. Claudins 
appear to be expressed in a tissue-specific behavior. Variations in the tightness of the tight 
junction appear to be determined by the combination and mixing ratios of different 
claudins. Different tissues have altered claudin profile, and it can be also changed by 
abnormal conditions. Claudins have a crucial role in the regulation of the selectivity of 
paracellular permeability; and their lack or overexpression can influence these changes 
(permeability and resistance). The nephron is a representative model of illustration the 
different functions of claudin (Li et al., 2004). The renal epithelia contain mostly all of the 
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subgroups of claudins according to the function of different areas of the nephron. Although 
claudins are expressed in all epithelial and endothelial tissues, mutations are frequently 
associated with diseases of the kidney, the skin and the ear. 
 
CLAUDINS CHARACTERISTICS, EXPRESSION IN DIFFERENT TISSUES (INCREASED ↑ OR 
DECREASED ↓) 
CLDN1  
‘tight’ 
epithelia 
Renal epithelia (collecting segment and proximal tubule), Epidermal barrier, 
Gallbladder, Ovarium, Inner ear, Brain capillary endothelium 
Breast cancer cell lines↓, Squamous cell cancer↓, Glioblastoma↓, Prostate AC↓ 
CLDN2 
‘leaky’ 
epithelia 
Renal epithelia (collecting segment and proximal tubule), Choroids plexus epithelium, 
Ovarium surface epithelium, Inner ear. 
Crohn’s disease↑  
CLDN3  
RVP1 
Capable of CPE binding 
Tighter segment of nephron, Gallbladder, Inner ear, Brain capillary endothelium, Liver 
and intestinal epithelial cells. 
Prostate AC↑, Ovarian CC↑, Colorectal CC↑, Breast CC↑, Glioblastoma↓, 
Encephalomyelitis↓ 
CLDN4  
CPE-R 
Selective CPE binding 
Tighter segment of nephron, Gallbladder. 
Pancreatic CC↑, Prostate AC↑, Ovarian CC↑, Colorectal CC↑, Breast CC↑ 
CLDN5  
 
Endothelial cells (e.g. brain), Ovarium surface epithelium, Colon epithelium, Retinal 
pigment epithelium during development. 
Glioblastoma↓, Cardiofacial syndrome↓, Crohn’s disease↓, Pancreatic CC↑ 
CLDN6 Embryonic epithelia 
CLDN7 Gastrointestinal tract, Tonsillar epithelium 
Head and neck squamous cell carcinoma↓, Stomach CC↑ 
CLDN8 Tighter segment of nephron, Gastrointestinal tract 
Crohn’s disease↓ 
CLDN9 Inner ear, Neonatal kidney 
CLDN10 Inner ear, Most segments of nephron 
CLDN11 
OSP 
Oligodendrocytes, Sertolli cells 
CLDN12 Inner ear, Brain endothelial cells, Gastrointestinal tract 
CLDN13 Gastrointestinal tract, Neonatal kidney 
CLDN14 Sensory epithelium (organ of Corti), Inner ear 
Nonsyndromic deafness↓ 
CLDN15 Kidney and Gastrointestinal tract endothelial cells 
CLDN16  
Paracellin-1 
Thick ascending limb of Henle (Mg2+ and Ca2+ resorption) 
Hypomagnesaemia, Hypercalciuria, nephrocalcinosis 
CLDN17 Kidney, Taste receptor cells 
CLDN18 
 
Lung and stomach, Inner ear 
Gastric CC↓ 
CLDN19 Kidney, Retina, Myelinated peripheral neurons, Schwann cells 
CLDN20 mRNA in skin 
CLDN21 Human DNA sequence 
CLDN22 mRNA in trachea 
CLDN23 mRNA in colon, stomach, placenta, skin 
CLDN24 Human DNA sequence 
Table 1. The characteristics and altered expression of claudins in different human tissues 
and cancers. Claudins were mostly investigated in the renal epithelium where the claudin 
pattern and the subsequent changes of permeability are easily followed by. (Abbreviations: 
CLDN: Claudin, AC: Adenocarcinoma, CC: Carcinoma, RVP: Rat Ventral Prostate, CPE: 
Clostridium Perfringens Enterotoxin, CPE-R: Clostridium Perfringens Enterotoxin Receptor, 
OSP: Oligodendrocyte Specific Protein) 
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Fig. 2. Schematic structure of claudin. 
3.1 Claudins and tumour of the gastrointestinal tract 
Altered claudin expression is associated with different disorders of the intestine (Table 2).  
 
Gastrointestinal tract Disorders and altered CLDN pattern (increased↑ or decreased↓ 
expression) 
 
Esophagus Barrett’s epithelia: CLDN2 and -3 ↑ 
Adenocarcinoma: CLDN2 and -3 ↑ 
Stomach Gastric metaplasia CLDN2,-3 and -4 ↑ 
Duodenum, Ileum, 
Jejunum 
Adenocarcinoma: CLDN2 ↑ 
GIST: CLDN2,-3, -4, -5 and -7 ↑ 
Angiosarcoma: CLDN2 and -5 ↑ 
Hemangioma: CLDN2 ↑ 
Leiomyoma: CLDN2 ↑ 
Leiomyosarcoma: CLDN1, -2, -3, -4, -5 and 7 ↑ 
Celiac disease: CLDN2 and -3 ↑ 
Gluten-intolerance: CLDN4 ↑ 
Colon Adenocarcinoma: CLDN2 ↑ 
IBD: CLDN2 ↑ and CLDN3, -4, -5 and -8 ↓ 
Table 2. Claudin expression in the gastrointestinal tract in different disorders. 
(Abbreviations: CLDN: Claudin, GIST: gastrointestinal stromal tumour, IBD: inflammatory 
bowel disease) 
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Since the damage of the cell-cell adhesion is an important role in the carcinogenesis, several 
papers have studied changes of claudins during tumor development and progression. All 
claudins were found in gastrointestinal carcinomas, and their expression was tumour-
specific. The Barrett's metaplasia of the esophagus requests attention for its precancerous 
behaviour (Thomson et al., 1983). Claudin2 and -3 expressions in Barrett’s esophagus were 
higher compared to the normal foveolar epithelium. The esophageal adenocarcinoma  
showed higher claudin2 and -3 expression compared with normal and Barrett’s epithelia. 
The similar claudin expression profile of Barrett’s esophagus and adenocarcinoma supports 
their sequential development (Győrffy et al., 2005). The low expression of the claudin4 is 
associated with the poor prognosis in the most common tumour of the esophagus, 
squamous cell carcinoma (Sung et al., 2011). Gastric intestinal metaplasia showed higher 
expression of claudin2, -3 and -4 as compared with normal antral foveolar mucosa (Győrffy, 
2009). Gastric adenocarcinoma expresses various claudin. Lower expression of claudin1 is 
common in the intestinal type of gastric adenocarcinoma according to Lauren classification 
(Jung et al., 2011). Claudin3 and -4 overexpression prevents the lymphatic invasion (Jung et 
al., 2011), but the overexpression of the claudin6, -7 and -9 increases the invasiveness of 
tumour cells in experimental model (Zavala-Zendejas, 2011). Claudin4 is a good general 
prognostic marker in the gastric adenocarcinoma (Jung et al., 2011). Autoantibodies against 
claudin18 prevent the development of the lung metastasis (Klamp et al., 2011). Tumours of 
small and large bowels exhibited higher claudin2 expression compared to normal epithelia 
(Győrffy, 2009). Decreased claudin4 expression correlates with the invasiveness and 
metastasis (Ueda et al., 2007). In addition, claudin18 overexpression is associated with poor 
prognosis of the colorectal cancer (Matsuda et al., 2010). However, colorectal adenoma and 
adenocarcinoma could not be differentiated according to their claudin profile (Győrffy, 
2009). 
3.2 Claudins and inflammatory bowel disease  
Beside the neoplastic or precancerous lesions, some of the inflammatory processes show 
alteration of the tight junctions. In inflammatory bowel diseases, including Crohn’s disease 
and ulcerative colitis, the intestinal barrier function is impaired due to deterioration in the 
structure of the epithelial tight junction. Claudin, as a key component of tight junction, 
might play an important role in the pathogenesis of inflammatory bowel diseases. In 
addition, tumour necrosis factor in inflammatory bowel diseases is upregulated, which 
induces barrier defects and is associated with the induction of claudin2 expression. 
Increased expression of claudin2 is detected along the inflamed crypt epithelium, whilst 
absent or barely detectable in normal colon (Weber et al., 2010). This higher expression of 
channel-forming claudin2 can cause reduced epithelial barrier in inflammatory bowel 
diseases (Suzuki et al., 2011). In the inflamed colonic mucosa of patients with ulcerative 
colitis, the protein expression of claudin1 was increased compared to non-inflamed 
ulcerative colitis colon and normal colon (Poritz et al., 2011). In addition, the higher 
expressions of claudin1 and -2 correlated positively with inflammatory activity of 
inflammatory bowel diseases and this increased expression may be involved at early stages 
of transformation in inflammatory bowel diseases -associated neoplasia (Weber et al., 2008). 
In experimental model of colitis in rats, significant decrease of claudin2, -12, -15 levels were 
detected in the colonic mucosa after dextrane-sodium sulphate induces colitis (Arimura et 
al., 2011). In contrast, some members of the claudin family such as claudin3 and -4 were 
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present throughout normal colonic epithelium and were reduced or redistributed in the 
inflamed surface epithelium (Prasad et al., 2005). Food components can strengthen the 
epithelial barrier as for example the flavonoid quercetin. Quercetin has been shown to 
upregulate claudin4 within the epithelial tight junction. This might be a therapeutic option 
in inflammatory bowel diseases patients to rebuild the tight junction complex (Hering et al., 
2009).  
3.3 Claudins and intestinal infections  
Claudins may serve as cell surface receptors for epithelial pathogens. Intestinal pathogens 
such as Vibrio cholerae, Salmonella, E. coli, Shigella, Giardia lamblia, and Rotavirus were 
found to directly alter tight junction permeability. Claudin3 and -4 have been shown to act 
as a receptor for C. perfringens enterotoxin (Katahira et al., 1997). Rotavirus infection of 
Caco-2 intestinal cells altered distribution of claudin1 and other tight junction proteins 
(Dickmann et al., 2000). In the pathogenesis of Helicobacter pylori infection, disruption of 
the tight junction implicated host cell signaling pathways including the dysregulation of 
claudin4 and -5 was observed (Fedwick et al., 2005). Moreover, claudin1, -6, and -9 are 
coreceptors for cellular entry of hepatitis C virus (Angelow et al., 2008). The importance of 
intestinal barrier function in the pathogenesis of necrotizing enterocolitis has been 
suggested in a rat model, where necrotizing enterocolitis was associated with increased 
claudin3 mRNA levels in both jejunum and ileum (Clark et al., 2006). 
3.4 Claudins in food allergy, obstructive jaundice and obesity 
In food allergy, mast cells are classically associated with allergen-induced immunoglobulin 
E mediated responses. Concerning our topic, mast cell deficient mice-model demonstrated 
dysregulation of claudin3 expression (Gorschwitz et al., 2009). Furthermore, claudin1 
expression was elevated in the small intestine in patients with food allergy (Pizzuti et al., 
2011). Experimental and clinical studies have shown that there is an increased intestinal 
permeability permitting the escape of endotoxin from gut lumen in patients with obstructive 
jaundice. In these subjects, claudin1 and -7 were significantly decreased whereas claudin4 
expression was increased. This pattern may be a key factor contributing to the disintegration 
of mucosal barrier (Assimakopoulos et al., 2011). Recently, obesity and diabetes have been 
characterized by low-grade chronic systemic inflammation. According to a novel 
hypothesis, this systemic inflammation is closely linked to the plasma endotoxemia due to 
increased intestinal permeability in obese animals (Cani et al., 2008). It is of interest, that 
excessive dietary fat increased small intestinal permeability resulting from the suppression 
of tight junction protein expression. Claudin1 and -3 were influenced by diet.  
4. Tight junctions and its effect on intestine in celiac disease 
4.1 Celiac disease and intestinal barrier function 
Deterioration of intestinal barrier function is one of the most important steps in the 
pathomechanism of celiac disease (Sapone et al, 2011). According to functional, structural 
and molecular analyses, intercellular junctions between epithelial cells are abnormal in the 
gut of patients with celiac disease (Madara et al, 1987; Poritz et al, 2011). Decreased 
intestinal barrier function leads to a continuous abnormal passage of antigens through the 
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epithelial layer. The main antigen of gluten in wheat, the gliadin can regulate cell activation, 
especially inhibits cell development and induces apoptosis. Gliadin almost immediately can 
change the barrier function of the intestinal mucosa inducing a reorganization of actin 
filaments and altered expression of different tight junction proteins (Drago et al, 2006; 
Fasano et al., 2000). In a human Caco-2 intestinal epithelial cell-model, gliadin altered 
barrier function almost immediately by decreasing transepithelial resistance and increasing 
permeability to small molecules (4 kDa). In addition, gliadin induced a reorganisation of 
actin filaments and altered expression of the tight junction proteins occludin, claudin3 and -
4, the tight junction-associated protein zonula occludens-1 and the adherens junction protein 
E-cadherin (Sander et al., 2005). The activation of T helper 1 and T helper 17 cells results 
tissue damage and disrupts barrier function. Namely, expression of interleukin-17A, 
interferon-gamma and interleukin-6 is enhanced and leads to increased immune reaction 
and promotes differentiation. On the other hand, reduced function of adaptive immunity is 
also detected. Decreased regulatory T cells in the epithelial mucosa are related to disturbed 
adaptive capacity. In addition, upregulation of regulatory T cell markers (like FoxP3 and 
tranforming growth factor-beta) was reported which phenomenon may be explained as a 
secondary compensatory response to injury. 
4.2. Claudins and the gut microbiota 
The intestinal epithelium is one of the most immunologically active surfaces in the body. 
Beside the barrier function, immunological reactions against food antigens and toxins are 
involved in the maintenance of healthy gut status. However, inappropriate increase of the 
immune response can lead to decreasing tolerance and intestinal immune disorders (e.g. 
celiac disease). The commensal bacteria and their dynamic interaction of the host gut play 
an essential role in the preservation of gut homeostasis. Intestinal flora is involved in the 
regulation of gut intestinal epithelial cells, maintenance of barrier function, and also in the 
restitution and reformation (stabilization) of tight junctions (Yu et al., 2012). 
Highlighting the importance of claudins, recent studies suggested that invasive bacterial 
pathogens (e.g. Streptococcus pneumonia and Haemophilus influenza) decrease the CLDN7 and 
-10 expression via TLR-dependent pathway leading decreased integrity of the epithelial cells 
(Clarke et al., 2011). This mechanism due to epithelial opening and bacterial translocation 
through the epithelial layer leads increased permeability and bacterial invasion.  
Recent studies suggested that the altered intestinal microbiota plays a role in the 
development of different disorders such as celiac disease, inflammatory bowel diseases and 
irritable bowel syndrome. In celiac disease, rodent studies suggest that gut microbiota 
influences mucosal integrity and plays a role in the early pathogenesis of CD (Cinova et al., 
2011). In human celiac disease, intestinal flora may be a key component switching oral 
tolerance to immune response against gliadin (Ray et al., 2012). In celiac disease, intestinal 
dysbiosis, along with increased Gram-negative bacteria and decreased Bifidobacteria was 
determined (Sanz et al., 2011). Infants who developed CD later in life had an unstable and 
immature microbiome with decreased abundance of the phylum Bacteriodetes along with 
high amount of Firmicutes compared to healthy individuals (Sellitto et al., 2012). The 
metabolomic analysis reveals increased lactate in CD which may be a predicting factor of 
CD. 
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5. Claudins and celiac disease 
5.1. Claudin-protein level in patients with celiac disease 
To the best of our knowledge, there is only one study to address the question to determine 
the expression of different claudin proteins in patients with celiac disease. The aim of this 
prospective study was to compare claudin2, -3 and -4 expressions in proximal and distal 
part of duodenum in children with celiac disease and in controls (Szakal et al., 2010). Biopsy 
samples from the proximal and distal part of duodenum were taken from newly diagnosed 
children with celiac disease. The villous/crypt ratio and the percentage of lymphocytes in 
the intraepithelial region using monoclonal CD3 antibodies were determined (Marsh 
scoring). The expression pattern of claudins in the duodenal mucosa was investigated by 
immunohistochemistry. The monoclonal anti-claudin2 and -4 and the polyclonal anti-
claudin3 antibodies were purified from rabbit antiserum. For visualization, biotinilated goat 
anti-rabbit secondary antibody and standard avidin-biotin peroxidase technique with 
diaminobenzidine were used as chromogen. The number of positive cells was calculated in 
the surface epithelium (with 100 enterocytes) on the top of the villi. Increased expression of 
claudin2 and -3 was detected in distal part of duodenal mucosa in pediatric patients with 
celiac disease compared to the proximal region and controls. It should be emphasized that 
claudin4 expression was comparable between the different groups studied (see later).  
Moreover, there was an association between expression of claudin and the grade of atrophy. 
Changes in the composition and the overturn of the different types of claudin may lead to 
structural alteration of tight junctions. This phenomenon may be responsible for the 
increased permeability and the modified cell-to-cell adhesion in the pathomechanism of 
celiac disease. In addition, comparative substudy showed that both proximal and distal 
parts of duodenum are also reliable for taking biopsy sample to prove villous atrophy. 
However, using sensitive methods, the distal part of duodenum depicted earlier signs of 
mucosal deterioration. Histological scoring grade (Marsh classification), the percentage of 
CD3 positive T cells and the expression of different claudin showed slightly more severity in 
the distal part of duodenum compared to the bulbus duodeni.  
5.2 Claudin-mRNA expression in celiac disease and gluten-sensitive disease 
As described previously, celiac disease is an autoimmune enteropathy triggered by the 
ingestion of gluten. Gluten sensitive individuals cannot tolerate gluten and may develop 
gastrointestinal symptoms similar to those in celiac disease. However, in contrast to celiac 
disease, the overall clinical picture is generally less severe and is not accompanied by the 
elevation of tissue transglutaminase autoantibodies or autoimmune comorbidities (Sapone, 
2011). In this study, innate and adaptive immunity in celiac disease were compared with 
gluten sensitivity. Intestinal permeability was evaluated using a lactulose and mannitol probe, 
and mucosal biopsy specimens were collected to study the expression of genes involved in 
barrier function and immunity. In contrast to celiac disease, gluten sensitivity was not 
associated with increased intestinal permeability. In fact, this was significantly reduced in 
gluten sensitive individuals compared to controls paralleled by significantly increased mRNA 
expression of claudin4. In comparison to controls, adaptive immunity markers interleukin-6 
and interleukin-21 were significantly increased in celiac disease but not in gluten sensitivity, 
while expression of the innate immunity marker Toll-like receptor 2 was increased in gluten 
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sensitive individuals but not in celiac disease. In addition, expression of the T-regulatory cell 
marker FOXP3 was significantly reduced in gluten sensitive individuals relative to controls 
and celiac disease patients. Authors concluded, that the two gluten-associated disorders, celiac 
disease and gluten sensitivity, are different clinical entities, and it contributes to the 
characterization of gluten sensitivity as a condition associated with prevalent gluten-induced 
activation of innate, rather than adaptive immune responses. In addition, previous study 
conducted by Szakal et al showed no elevation of claudin4 in the intestinal mucosa of patients 
with celiac disease (Szakal, 2010). This finding strengthen the hypothesis of Sapone et al that 
claudin4 could be an important marker to differentiate between celiac disease and gluten 
sensitivity (Sapone, 2011). Further studies are necessary to characterize gluten sensitivity as a 
well-defined entity in the family of celiac-related disorders.  
6. Conclusion and future remarks 
Gluten-induced changes in the tight junction and the ratio of claudins influence immune 
processes and barrier mechanism underlying celiac disease pathogenesis. As sensitive 
methods, detection of claudins in the upper gastrointestinal tract may help to detect 
abnormalities in an early stage and provide information to determine the prognosis of celiac 
disease (Szakal et al., 2010; Prasad et al, 2005; Visser et al, 2009). Nevertheless, modification 
of claudins and tight junction might be therapeutic approach in the future. Furthermore, 
influence of tight junctions’ regulation may be a novel approach of treatment in several 
diseases due to the fact that celiac disease may serve as a model for other autoimmune 
disorders. The advantage in celiac disease is that the causative agent (gluten) is well known 
compared to other autoimmune disorders such as in inflammatory bowel diseases. 
Development of agents making tight junctions close might be used as anti-inflammatory, 
anti-metastatic and anti-diarrhea drugs. In contrast, drugs opening tight junctions are new 
applications of treating tumors and help reaching closed compartment of the body (e.g. 
brain-blood barrier).  
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